ESC 365 - Prevalence of ICD therapies in primary prevention vs secondary prevention in a sample of patients diagnosed with arrhythmogenic cardiomyopathy

Open Access

Prevalence of ICD therapies in primary prevention vs secondary prevention in a sample of patients diagnosed with arrhythmogenic cardiomyopathy

Session: Cardiovascular implantable electronic device in patients with heart failure

Topic: Implantable Cardioverter-Defibrillator (ICD)

Speaker: Doctor A. Diaz Exposito (Malaga, ES)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Doctor Arancha Diaz Exposito

Virgin of Victory University Hospital, Malaga (Spain)

7 presentations

0 follower

6 more presentations in this session

Non-conventional versus conventional pacing in cardiac amyloidosis: impact on clinical, electrical, and functional outcomes

Speaker: Doctor M. Lima (Lisbon, PT)

Predictors for adverse outcomes in ICD/CRT-D patients: insights from a single-center study

Speaker: Doctor S. Andraz (Faro, PT)

What makes hearts race in cardiac implantable electronic device patients?

Speaker: Doctor M. Rodrigues Simoes (Coimbra, PT)

Left bundle branch area pacing versus biventricular pacing upgrade in pacemaker-induced cardiomyopathy: a comparison of short-term outcomes

Speaker: Doctor B. Dobai (Targu Mures, RO)

Left Bundle Branch Area Defibrillation (LBBAD) using ICD lead in the LBBAP position

Speaker: Doctor A. Briski (Duesseldorf, DE)

Access the full session

Cardiovascular implantable electronic device in patients with heart failure

Speakers: Doctor A. Diaz Exposito, Doctor M. Lima, Doctor S. Andraz, Doctor M. Rodrigues Simoes, Doctor B. Dobai...

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources